ADMA BIOLOGICS, INC. Earnings Per Share, Basic and Diluted
ADMA BIOLOGICS, INC. (ADMA) reported Earnings Per Share, Basic and Diluted of -$0.16 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-12
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.16.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.19.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.23.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.26.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.88.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.89.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.45.
- ADMA BIOLOGICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.91.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.16 10-Q · filed 2021-05-12 | |||||||
| 2020-12-31 | -$0.88 10-K · filed 2021-03-25 | |||||||
| 2020-09-30 | -$0.19 10-Q · filed 2020-11-05 | -$0.68 10-Q · filed 2020-11-05 | ||||||
| 2020-06-30 | -$0.23 10-Q · filed 2020-08-05 | -$0.49 10-Q · filed 2020-08-05 | ||||||
| 2020-03-31 | -$0.26 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | -$0.89 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | -$0.19 10-Q · filed 2020-11-05 | -$0.72 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -$0.25 10-Q · filed 2020-08-05 | -$0.53 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | -$0.28 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | -$0.39 10-K · filed 2019-03-13 | -$1.45 10-K · filed 2020-03-13 | ||||||
| 2018-09-30 | -$0.33 10-Q · filed 2019-11-06 | -$1.06 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | -$0.35 10-Q · filed 2019-08-08 | -$0.74 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | -$0.39 10-Q · filed 2019-05-08 | |||||||
| 2017-12-31 | -$1.91 10-K · filed 2019-03-13 | |||||||
| 2017-09-30 | -$0.59 10-Q · filed 2018-11-09 | -$1.67 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | -$0.55 10-Q · filed 2018-08-10 | -$1.06 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | -$0.51 10-Q · filed 2018-05-14 | |||||||
| 2016-12-31 | -$1.61 10-K · filed 2018-03-29 | |||||||
| 2016-09-30 | -$0.34 10-Q · filed 2017-11-03 | -$1.26 10-Q · filed 2017-11-03 | ||||||
| 2016-06-30 | -$0.50 10-Q · filed 2017-08-11 | -$0.93 10-Q · filed 2017-08-11 | ||||||
| 2016-03-31 | -$0.43 10-Q · filed 2017-05-12 | |||||||
| 2015-12-31 | -$1.73 10-K · filed 2017-02-24 | |||||||
| 2015-09-30 | -$0.48 10-Q · filed 2016-11-10 | -$1.28 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | -$0.44 10-Q · filed 2016-08-12 | -$0.81 10-Q · filed 2016-08-12 | ||||||
| 2015-03-31 | -$0.37 10-Q · filed 2016-05-13 | |||||||
| 2014-12-31 | -$1.81 10-K · filed 2016-03-23 | |||||||
| 2014-09-30 | -$0.36 10-Q · filed 2015-11-10 | -$1.43 10-Q · filed 2015-11-10 | ||||||
| 2014-06-30 | -$0.43 10-Q · filed 2015-08-11 | -$1.06 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | -$0.64 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | -$2.38 10-K · filed 2015-03-09 | |||||||
| 2013-09-30 | -$0.46 10-Q · filed 2014-11-10 | -$1.84 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | -$0.83 10-Q · filed 2014-08-11 | -$1.39 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | -$0.55 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$1.39 10-K · filed 2014-03-28 | -$1.76 10-K · filed 2013-03-06 | ||||||
| 2012-09-30 | -$0.55 10-Q · filed 2013-11-12 | -$0.70 10-Q · filed 2012-11-13 | -$1.00 10-Q · filed 2013-11-12 | -$1.27 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | -$0.20 10-Q · filed 2013-08-12 | -$0.26 10-Q · filed 2012-08-14 | -$0.39 10-Q · filed 2013-08-12 | -$0.49 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | -$0.18 10-Q · filed 2013-05-14 | -$0.23 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $0.00 10-Q · filed 2012-02-01 | $0.00 10-Q · filed 2012-02-01 | -$16.72 10-K · filed 2013-03-06 | |||||
| 2011-09-30 | -$2.79 10-Q · filed 2012-11-13 | $0.00 10-Q · filed 2011-10-28 | -$14.08 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | -$6.79 10-Q · filed 2012-08-14 | -$11.29 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$4.50 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-01 | $0.00 10-Q · filed 2012-02-01 | ||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |